Repurposing Research for Chicago 2026: Track 2 – Patient Groups supports Chicago-area researchers testing repurposed therapies to address unsolved diseases in underserved and priority patient groups.
ALS Finding a Cure funds research using AI and NLP to advance ALS diagnostics, biomarker discovery, disease modeling, and therapeutic innovation.
The Repurposing Generic (ReGen) Drugs Evidence Package Challenge from NIH Challenges seeks strong scientific evidence for generic drugs as affordable treatments for costly diseases.
This grant seeks to develop AI/ML models using real-world data to monitor clinical outcomes when patients switch between complex generics and brand-name drugs.
CRI Clinical Innovator supports academic researchers leading early-phase cancer immunotherapy trials to test novel treatments, study response mechanisms, and identify biomarkers to improve patient outcomes.